A detailed history of Evercore Wealth Management, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Evercore Wealth Management, LLC holds 5,000 shares of CRL stock, worth $829,350. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,000
Holding current value
$829,350
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$187.96 - $245.29 $939,800 - $1.23 Million
5,000 New
5,000 $984,000
Q4 2023

Feb 14, 2024

SELL
$164.52 - $238.84 $411,300 - $597,100
-2,500 Reduced 49.96%
2,504 $591,000
Q3 2023

Nov 14, 2023

BUY
$194.44 - $217.61 $777 - $870
4 Added 0.08%
5,004 $980,000
Q2 2023

Aug 04, 2023

BUY
$183.71 - $210.25 $459,275 - $525,625
2,500 Added 100.0%
5,000 $1.05 Million
Q1 2023

May 15, 2023

BUY
$191.89 - $259.92 $479,724 - $649,800
2,500 New
2,500 $504,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.44B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Evercore Wealth Management, LLC Portfolio

Follow Evercore Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evercore Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evercore Wealth Management, LLC with notifications on news.